<DOC>
	<DOCNO>NCT01525758</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety SI000413 patient knee osteoarthritis orally administration determine optimal dose .</brief_summary>
	<brief_title>Study SI000413 Knee Osteoarthritis Patients</brief_title>
	<detailed_description>This dose-response , double blind , placebo-controlled study . All patient require 2 week washout period prior medication . Subjects discontinue current medication 2 week prior randomization . Among meet inclusion criterion , subject record visual analogue scale ( VAS ) high 40mm ( VAS range 0mm ( pain ) 100mm ( unbearable pain ) ) enrol study . Subjects meet screen criterion randomize receive 8 week dose active dose SI000413 placebo .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Males female , 3575 year old 2 . Subjects must clinical radiographic diagnosis primary OA knee ( diagnose accord ACR ) The presence knee pain At least one follow age old 50 year morning stiffness last less 30 minute crepitus motion 3 . Subjects must symptomatic least 3 month prior enrollment . 4 . Subjects must require experienced pain intensity least 40mm 100mm visual analogue scale severely affect joint 24 hour prior randomization . 5 . Adequate liver kidney function Adequate liver function : SGOT , SGPT must within 1.5 x normal limit Adequate kidney function : Serum creatinine must within 1.5 x normal limit 6 . Subjects must able read , understand follow study instruction 7 . Subjects must agree informed consent spontaneously . 1 . Subjects use adequate birth control . 2 . Pregnant breastfeeding . 3 . Subjects require Knee surgery within 1 year screen anticipate need surgical procedure study . 4 . Secondary OA patient 5 . Similar OA patient ( ex . rheumatic arthritis , bursitis etc ) 6 . Treatment intraarticular injection systemic corticosteroid hyaluronic acid prior 3 month . 7 . Use drug psychotropic medicine ( methadone maintenance program , codeine , tramadol hydrochloride ) 8 . Anemia coagulant disorder 9 . Use anticoagulant lithium 10 . Use misoprostol H2blocker ( include anti ulcer medicine ) 11 . Presence history gastrointestinal bleeding within past 1 year . 12 . Subjects serious problem cardiovascular , respiratory , endocrine , central nervous History neurotic mental . 13 . Active malignancy type ( ex . lymphoma , multiple myeloma etc ) 14 . Use medication affect pain perception study period ; physical therapy , corticosteroid , NSAIDs , asprin , topical analgesic . 15 . Use glucosamine , chondroitin study period . 16 . Change concomitant dose/use within 4 week . 17 . Known allergy hypersensitivity medicine . 18 . Subjects receive hormone replacement therapy . 19 . Use investigational drug within 1 month prior screen . 20 . Investigators determine appropriate .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>